Published in Pharmacoepidemiol Drug Saf on August 01, 2010
Olfactory dysfunction predicts 5-year mortality in older adults. PLoS One (2014) 1.13
Patient weighting of osteoporosis medication attributes across racial and ethnic groups: a study of osteoporosis medication preferences using conjoint analysis. Osteoporos Int (2012) 0.98
Racial disparities in olfactory loss among older adults in the United States. J Gerontol A Biol Sci Med Sci (2013) 0.94
Race, ethnicity, and state-by-state geographic variation in hemorrhagic stroke in dialysis patients. Clin J Am Soc Nephrol (2014) 0.93
Racial differences in antilipemic use and lipid control in high-risk older adults: post-Medicare Part D. Am Heart J (2013) 0.87
Association of vascular risk factors with cognition in a multiethnic sample. J Gerontol B Psychol Sci Soc Sci (2014) 0.87
Year in review: medication mishaps in the elderly. Am J Geriatr Pharmacother (2011) 0.86
Impact of race on cumulative exposure to antihypertensive medications in dialysis. Am J Hypertens (2012) 0.86
A National Assessment of Medication Adherence to Statins by the Racial Composition of Neighborhoods. J Racial Ethn Health Disparities (2016) 0.81
Methods for estimation of disparities in medication use in an observational cohort study: results from the Multi-Ethnic Study of Atherosclerosis. Pharmacoepidemiol Drug Saf (2013) 0.81
Racial disparities in quality of medication use in older adults: findings from a longitudinal study. Am J Geriatr Pharmacother (2011) 0.79
Pharmacy accessibility and cost-related underuse of prescription medications in low-income Black and Hispanic urban communities. J Am Pharm Assoc (2003) (2017) 0.78
Use of secondary prevention medications among adults with reduced kidney function. Clin J Am Soc Nephrol (2012) 0.77
Geographic variation in HMG-CoA reductase inhibitor use in dialysis patients. J Gen Intern Med (2012) 0.77
Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009. Ann Vasc Surg (2015) 0.76
Just because it's low cost doesn't mean it's accessible. J Gen Intern Med (2012) 0.75
Cardiovascular care guideline implementation in community health centers in Oregon: a mixed-methods analysis of real-world barriers and challenges. BMC Health Serv Res (2017) 0.75
Addressing Stroke Risk Factors in Black and White Americans: Findings from the National Health and Nutrition Examination Survey, 2009-2010. Ethn Dis (2016) 0.75
Statin and Aspirin Use Among Hispanic and Latino Adults at High Cardiovascular Risk: Findings From the Hispanic Community Health Study/Study of Latinos. J Am Heart Assoc (2016) 0.75
What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA (1998) 26.79
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Can comorbidity be measured by questionnaire rather than medical record review? Med Care (1996) 10.53
A study of sexuality and health among older adults in the United States. N Engl J Med (2007) 9.66
State of disparities in cardiovascular health in the United States. Circulation (2005) 9.32
"We don't carry that"--failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med (2000) 7.56
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Racial disparities in the quality of care for enrollees in medicare managed care. JAMA (2002) 6.35
Disparities in health care by race, ethnicity, and language among the insured: findings from a national sample. Med Care (2002) 5.81
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA (2008) 5.27
Statistical design and estimation for the national social life, health, and aging project. J Gerontol B Psychol Sci Soc Sci (2009) 5.01
Patient-physician communication about out-of-pocket costs. JAMA (2003) 4.47
Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med (2007) 3.34
The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol (2003) 3.26
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother (2008) 3.20
The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol (2004) 3.08
Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health (2004) 2.86
Transforming insurance coverage into quality health care: voltage drops from potential to delivered quality. JAMA (2000) 2.62
An overview of cardiovascular disease burden in the United States. Health Aff (Millwood) (2007) 2.40
Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol (2008) 2.33
Racial disparities in self-rated health at older ages: what difference does the neighborhood make? J Gerontol B Psychol Sci Soc Sci (2005) 2.33
Racial segregation and longevity among African Americans: an individual-level analysis. Health Serv Res (2003) 2.22
Trust in the health care system and the use of preventive health services by older black and white adults. Am J Public Health (2008) 2.04
Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med (2007) 1.87
Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev (2007) 1.83
Social context as an explanation for race disparities in hypertension: findings from the Exploring Health Disparities in Integrated Communities (EHDIC) Study. Soc Sci Med (2008) 1.63
Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System. Am J Prev Med (2006) 1.48
Racial differences in the use of aspirin: an important tool for preventing heart disease and stroke. Ethn Dis (2005) 1.46
The geographic accessibility of retail clinics for underserved populations. Arch Intern Med (2009) 1.44
National trends in statin use by coronary heart disease risk category. PLoS Med (2005) 1.41
Racial/ethnic inequities in continuity and site of care: location, location, location. Health Serv Res (2001) 1.41
Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease. PLoS Med (2005) 1.41
Quality of US outpatient care: temporal changes and racial/ethnic disparities. Arch Intern Med (2005) 1.37
Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med (2002) 1.35
The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol (1999) 1.31
Segregation and disparities in health services use. Med Care Res Rev (2009) 1.29
Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol (2007) 1.21
Medication data collection and coding in a home-based survey of older adults. J Gerontol B Psychol Sci Soc Sci (2009) 1.20
Examining racial and ethnic disparities in site of usual source of care. J Natl Med Assoc (2007) 1.17
Racial segregation and health disparities between Black and White older adults. J Gerontol B Psychol Sci Soc Sci (2006) 1.14
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program. JAMA (1999) 0.87
Prevention of cardiovascular disease: risks and benefits of aspirin. J Gen Intern Med (1990) 0.78
Aspirin for primary prevention. Doctors and patients should understand potential benefits and risks of aspirin treatment. BMJ (2000) 0.77
Use of statins and aspirin to reduce risks of cardiovascular disease. J Cardiovasc Pharmacol Ther (2002) 0.77
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
A study of sexuality and health among older adults in the United States. N Engl J Med (2007) 9.66
Lying to insurance companies: the desire to deceive among physicians and the public. Am J Bioeth (2004) 8.49
Neighborhoods, obesity, and diabetes--a randomized social experiment. N Engl J Med (2011) 5.72
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA (2008) 5.27
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med (2008) 4.33
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Reconsidering medication appropriateness for patients late in life. Arch Intern Med (2006) 3.81
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet (2009) 3.65
Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health (2009) 3.13
Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2012) 2.78
The Social Connectedness of Older Adults: A National Profile* Am Sociol Rev (2008) 2.45
National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes (2012) 2.27
The Food and Drug Administration Amendments Act and postmarketing commitments. JAMA (2013) 2.27
Of more than one mind: obstetrician-gynecologists' approaches to morally controversial decisions in sexual and reproductive healthcare. J Clin Ethics (2008) 2.25
Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med (2010) 2.05
National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation. Arch Intern Med (2005) 2.01
Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. Pharmacoepidemiol Drug Saf (2013) 1.97
The role of surgeon error in withdrawal of postoperative life support. Ann Surg (2012) 1.97
The physician-surrogate relationship. Arch Intern Med (2007) 1.93
Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care (2012) 1.91
Substituted judgment: the limitations of autonomy in surrogate decision making. J Gen Intern Med (2008) 1.88
The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health (2015) 1.86
What we don't talk about when we don't talk about sex: results of a national survey of U.S. obstetrician/gynecologists. J Sex Med (2012) 1.80
General internists' views on pay-for-performance and public reporting of quality scores: a national survey. Health Aff (Millwood) (2007) 1.71
Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med (2007) 1.69
Promotion of prescription drugs to consumers and providers, 2001-2010. PLoS One (2013) 1.66
Social Networks in the NSHAP Study: rationale, measurement, and preliminary findings. J Gerontol B Psychol Sci Soc Sci (2009) 1.65
"I'm not just a heart, I'm a whole person here": a qualitative study to improve sexual outcomes in women with myocardial infarction. J Am Heart Assoc (2013) 1.60
Out-of-pocket and total costs of fixed-dose combination antihypertensives and their components. Am J Hypertens (2008) 1.60
Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy (2008) 1.58
Critical care physicians' approaches to negotiating with surrogate decision makers: a qualitative study. Crit Care Med (2012) 1.54
Surgeons expect patients to buy-in to postoperative life support preoperatively: results of a national survey. Crit Care Med (2013) 1.53
Surgeon-reported conflict with intensivists about postoperative goals of care. JAMA Surg (2013) 1.49
Changes in glitazone use among office-based physicians in the U.S., 2003-2009. Diabetes Care (2010) 1.46
Responding to an FDA warning--geographic variation in the use of rosiglitazone. N Engl J Med (2010) 1.46
Impact of abuse-deterrent OxyContin on prescription opioid utilization. Pharmacoepidemiol Drug Saf (2014) 1.42
Impact of a drug utilization review program on high-risk use of prescription controlled substances. Pharmacoepidemiol Drug Saf (2013) 1.42
Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care (2013) 1.40
Should editorials in peer-reviewed journals be signed? Chest (2006) 1.40
Recommendations to limit life support: a national survey of critical care physicians. Am J Respir Crit Care Med (2012) 1.39
Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents. Pharmacoepidemiol Drug Saf (2014) 1.39
Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants. J Clin Psychiatry (2016) 1.39
Mental health policy and psychotropic drugs. Milbank Q (2005) 1.38
National trends in ambulatory asthma treatment, 1997-2009. J Gen Intern Med (2011) 1.37
Sexuality: measures of partnerships, practices, attitudes, and problems in the National Social Life, Health, and Aging Study. J Gerontol B Psychol Sci Soc Sci (2009) 1.37
U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Pharmacoepidemiol Drug Saf (2009) 1.34
Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012. Diabetes Care (2013) 1.32
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). Inflamm Bowel Dis (2007) 1.26
Assessment of sensory function in the National Social Life, Health, and Aging Project. J Gerontol B Psychol Sci Soc Sci (2009) 1.23
Elderly patients' preferences and experiences with providers in managing their drug costs. J Am Geriatr Soc (2007) 1.21
Medication data collection and coding in a home-based survey of older adults. J Gerontol B Psychol Sci Soc Sci (2009) 1.20
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures. Health Serv Res (2009) 1.19
Physicians' experience with surrogate decision making for hospitalized adults. J Gen Intern Med (2009) 1.15
Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr (2012) 1.15
Salivary sex hormone measurement in a national, population-based study of older adults. J Gerontol B Psychol Sci Soc Sci (2009) 1.14
Physician consideration of patients' out-of-pocket costs in making common clinical decisions. Arch Intern Med (2007) 1.11
Socioeconomic disparities in ectopic pregnancy: predictors of adverse outcomes from Illinois hospital-based care, 2000-2006. Matern Child Health J (2011) 1.09
The impact of the Medicare Part D prescription benefit on generic drug use. J Gen Intern Med (2008) 1.08
Rethinking the ethical framework for surrogate decision making: a qualitative study of physicians. J Clin Ethics (2008) 1.03
Predictors of C-reactive protein in the national social life, health, and aging project. J Gerontol B Psychol Sci Soc Sci (2010) 0.99
The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility. Health Serv Res (2011) 0.98
Differential access to digital communication technology: association with health and health survey recruitment within an African-American underserviced urban population. J Urban Health (2011) 0.95
National prevalence of lifestyle counseling or referral among African-Americans and whites with diabetes. J Gen Intern Med (2008) 0.94
Assessing competence of residents to discuss end-of-life issues. J Palliat Med (2005) 0.93
Mind the gap: understanding the effects of pharmaceutical direct-to-consumer advertising. Med Care (2014) 0.93
Comments From the South Side of Chicago on New Haven's Inspiring Initiative. Am J Public Health (2012) 0.93
A Phase II study of oxaliplatin in urothelial cancer. Urol Oncol (2005) 0.92
Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010. Breast Cancer Res Treat (2012) 0.92
A qualitative exploration of depression in emerging adulthood: disorder, development, and social context. Gen Hosp Psychiatry (2007) 0.92
Physicians' views on the importance of patient preferences in surrogate decision-making. J Am Geriatr Soc (2010) 0.92
Should our well-child care system be redesigned? A national survey of pediatricians. Pediatrics (2006) 0.92
Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr (2015) 0.91
Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial. Stroke (2014) 0.89
Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory. Pharmacoepidemiol Drug Saf (2012) 0.89
Health plan utilization and costs of specialty drugs within 4 chronic conditions. J Manag Care Pharm (2013) 0.89
State Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning. Health Aff (Millwood) (2012) 0.88
Trends in kidney donation among kidney stone formers: a survey of US transplant centers. Am J Nephrol (2009) 0.87
A pediatric-focused review of the performance incentive literature. Curr Opin Pediatr (2007) 0.86
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. Psychiatr Serv (2013) 0.86
Design and evaluation of a workplace intervention to promote organ donation. Prog Transplant (2006) 0.86
Using performance data to identify preferred hospitals. Health Serv Res (2007) 0.86
Are your asset data as good as you think? Conducting a comprehensive census of built assets to improve urban population health. J Urban Health (2013) 0.86
Influence of patient race on physician prescribing decisions: a randomized on-line experiment. J Gen Intern Med (2009) 0.85
The "Hassle Factor": what motivates physicians to manipulate reimbursement rules? Arch Intern Med (2002) 0.84
Improving the Food and Drug Administration's mandate to ensure postmarketing drug safety. JAMA (2011) 0.84
The association between family structure, reports of illness and health care demand for children: evidence from rural Bangladesh. J Biosoc Sci (2009) 0.84
A qualitative study of physicians' engagement in reducing healthcare disparities. J Natl Med Assoc (2007) 0.83